These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11903753)

  • 1. Therapeutic effects on intestinal Behçet's disease of an intravenous drug delivery system using dexamethasone incorporated in lipid emulsion.
    Nakase H; Okazaki K; Kawanami C; Uchida K; Ohana M; Uose S; Nishi T; Itoh T; Okano A; Nishio A; Takakuwa H; Chiba T
    J Gastroenterol Hepatol; 2001 Nov; 16(11):1306-8. PubMed ID: 11903753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of intraarterial prednisolone injection in severe intestinal Behçet's disease.
    Toda K; Shiratori Y; Yasuda M; Enya M; Uematsu T; Shimazaki M; Fukutomi Y; Kato T; Moriwaki H
    J Gastroenterol; 2002; 37(10):844-8. PubMed ID: 12424569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beneficial effect of mesalazine on esophageal ulcers in intestinal Behcet's disease.
    Sonta T; Araki Y; Koubokawa M; Tamura Y; Ochiai T; Harada N; Chijiiwa Y; Nawata H
    J Clin Gastroenterol; 2000 Mar; 30(2):195-9. PubMed ID: 10730926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
    Ju JH; Kwok SK; Seo SH; Yoon CH; Kim HY; Park SH
    Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjunctival ulcer--mucocutaneous or ocular manifestation of Behçet's disease? A case report.
    Shenoy R
    Eur J Ophthalmol; 2002; 12(5):435-6. PubMed ID: 12474929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of intestinal Behçet's disease treated with infliximab monotherapy who successfully maintained clinical remission and complete mucosal healing for six years.
    Maruyama Y; Hisamatsu T; Matsuoka K; Naganuma M; Inoue N; Ogata H; Iwao Y; Kanai T; Hibi T
    Intern Med; 2012; 51(16):2125-9. PubMed ID: 22892489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked improvement in gastric involvement in Behçet's disease with adalimumab treatment.
    Sonoda A; Ogawa R; Mizukami K; Fukuda K; Shuto M; Okamoto K; Matsunari O; Okimoto T; Murakami K
    Turk J Gastroenterol; 2017 Sep; 28(5):405-407. PubMed ID: 28797990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case.
    Byeon JS; Choi EK; Heo NY; Hong SC; Myung SJ; Yang SK; Kim JH; Song JK; Yoo B; Yu CS
    Dis Colon Rectum; 2007 May; 50(5):672-6. PubMed ID: 17216141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occlusive retinal vasculitis secondary to Behçet's disease.
    Tien PT; Lin HJ; Chen WL; Lin CJ; Lin JM; Tsai YY
    Postgrad Med J; 2017 Feb; 93(1096):106. PubMed ID: 27489374
    [No Abstract]   [Full Text] [Related]  

  • 10. Is intestinal Behçet's disease in fact an enterocolitis or an ulcer disease, and is steroid treatment useful or harmful?
    Takada Y; Saigenji K
    J Gastroenterol; 2003; 38(10):1015-6. PubMed ID: 14614614
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion.
    Mizushima Y; Hamano T; Yokoyama K
    Ann Rheum Dis; 1982 Jun; 41(3):263-7. PubMed ID: 6896429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
    Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody.
    Travis SP; Czajkowski M; McGovern DP; Watson RG; Bell AL
    Gut; 2001 Nov; 49(5):725-8. PubMed ID: 11600479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic therapy with absolute ethanol for postoperative recurrent ulcers in intestinal Behçet's disease, and simple ulcers.
    Matsukawa M; Yamasaki T; Kouda T; Kurihara M
    J Gastroenterol; 2001 Apr; 36(4):255-8. PubMed ID: 11324729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.
    Park J; Cheon JH
    Gut Liver; 2018 Nov; 12(6):623-632. PubMed ID: 29788675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjunctival ulcers in Behçet's disease.
    Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA
    Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Myelodysplastic Syndrome with Intestinal Behçet's Disease-Like Symptoms Treated by Prednisolone and Azacitidine.
    Endo M; Sekikawa A; Tsumura T; Maruo T; Osaki Y
    Am J Case Rep; 2015 Nov; 16():827-31. PubMed ID: 26590106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survey on intestinal Behçet's disease in Hokkaido (author's transl)].
    Sekiya C; Harada K; Namiki M
    Hokkaido Igaku Zasshi; 1981 Sep; 56(5):519-28. PubMed ID: 7319461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of Behçet's disease with multiple longitudinal ulcers all over the colon.
    Masugi J; Matsui T; Fujimori T; Maeda S
    Am J Gastroenterol; 1994 May; 89(5):778-80. PubMed ID: 8172155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease.
    Iwamoto J; Murakami M; Konishi N; Monma T; Ueda H; Yara S; Hirayama T; Ikegami T; Honda A; Matsuzaki Y
    Intern Med; 2018 Feb; 57(3):339-342. PubMed ID: 29093413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.